XPHYF News and Press, XPhyto Therapeutics Corp From 08/10/20

VANCOUVER, BC / ACCESSWIRE / August 10, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY / OTC PINK:XPHYF / FSE:4XT ) (" XPhyto " or the " Company "), a next generation bioscience company, is pleased to announce an update on its rapid COVID-19 (SARS-COV-2) screening test, near-term milestones...

VANCOUVER, BC / ACCESSWIRE / August 6, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY / FSE:4XT / OTC PINK:XPHYF ) (" XPhyto " or the " Company "), a next generation bioscience company, is pleased to announce that it will be presenting at Wall Street Reporter's "Next Super Stock" livestrea...

Vancouver, British Columbia--(Newsfile Corp. - July 6, 2020) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC Pink: XPHYF) ("XPhyto" or the "Company") is pleased to announce that its exclusive diagnostic partner, 3a-Diagnostics GmbH ("3a"), has confirmed successful function of its nov...

Vancouver, British Columbia--(Newsfile Corp. - July 1, 2020) -   XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC PINK: XPHYF) ("XPhyto" or the "Company") is pleased to announce that it has entered into an investor relations consulting agreement (the "Agreement") with Knox Communica...

VANCOUVER, BC / ACCESSWIRE / June 29, 2020 / XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC PINK:XPHYF) ("XPhyto" or the "Company") is pleased to announce that its diagnostic partner, 3a-Diagnostics GmbH ("3a"), has confirmed active functionality of peptide biosensors that were incorpo...

Vancouver, British Columbia--(Newsfile Corp. - June 15, 2020) - XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC Pink: XPHYF) ("XPhyto" or the "Company") is pleased to announce that its wholly owned German subsidiary, Vektor Pharma TF GmbH ("Vektor"), has successfully incorporated pept...

Vancouver, British Columbia--(Newsfile Corp. - June 10, 2020) -  XPhyto Therapeutics Corp. (CSE: XPHY) (FSE: 4XT) (OTC Pink: XPHYF) ("XPhyto" or the "Company") is pleased to announce that its diagnostic partner, 3a-Diagnostics GmbH ("3a") and their contract research collaborators, have ...

VANCOUVER, BC / ACCESSWIRE / June 8, 2020 / XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC:XPHYF) ("XPhyto" or the "Company") is pleased to announce that its wholly owned German subsidiary, Vektor Pharma TF GmbH ("Vektor"), has finalized the formula for its novel transdermal delivery s...

VANCOUVER, BC / ACCESSWIRE / April 22, 2020 / XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTCPINK:XPHYF) ("XPhyto" or the "Company") is pleased to announce that further to its press release on April 20, 2020, regarding a definitive development, technology purchase and licence agreement ...

VANCOUVER, BC / ACCESSWIRE / April 20, 2020 / XPhyto Therapeutics Corp. (CSE:XPHY / FSE:4XT / OTC PINK:XPHYF) ("XPhyto" or the "Company") is pleased to announce that it has signed a definitive development, technology purchase and licence agreement (the "Agreement") with 3a-Diagnostics GmbH ...